Pulmatrix (PULM) Non-Current Assets (2014 - 2026)
Pulmatrix (PULM) posted Non-Current Assets of $7000.0 for Q1 2026, down 30.0% sequentially from $10000.0 in Q4 2025, and down 30.0% YoY from $10000.0 in Q1 2025.
Pulmatrix (PULM) Non-Current Assets (2014 - 2026) Analysis & Trends
Pulmatrix has reported Non-Current Assets for 13 years, with the latest figure at $7000.0 in Q1 2026.
- Quarterly Non-Current Assets fell 30.0% year-over-year to $7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37000.0 (down 84.65% YoY) and the FY2025 annual result came in at $10000.0, down 56.52% from the prior year.
- Non-Current Assets fell to $7000.0 in Q1 2026 per PULM's latest filing, from $10000.0 in the prior quarter.
- Over five years, Non-Current Assets peaked at $13.5 million in Q3 2023 and troughed at $7000.0 in Q1 2026.
- A 5-year average of $3.5 million and a median of $2.8 million in 2022 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets jumped 367.39% in 2023, then sank 99.92% in 2025.
- Over 5 years, Non-Current Assets stood at $2.8 million in 2022, then surged by 367.39% to $13.1 million in 2023, then tumbled by 99.82% to $23000.0 in 2024, then plunged by 56.52% to $10000.0 in 2025, then fell by 30.0% to $7000.0 in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $7000.0, $10000.0, and $10000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 18.06 Bn |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 144,000.00 |
| Mar 31, 2024 | 12.81 Mn |
| Dec 31, 2023 | 13.12 Mn |
| Sep 30, 2023 | 13.54 Mn |
| Jun 30, 2023 | 4.01 Mn |
| Mar 31, 2023 | 3.26 Mn |
| Dec 31, 2022 | 2.81 Mn |
| Sep 30, 2022 | 3.23 Mn |
| Jun 30, 2022 | 3.55 Mn |
| Mar 31, 2022 | 3.70 Mn |
| Dec 31, 2021 | 4.04 Mn |
| Sep 30, 2021 | 1.31 Mn |